TABLE 1.

Demographic and Clinical Data of IBD Patients Enrolled

UC	Demographic and Clinical Characteristics
Sex	11 F; 18 M (62%M and 38% F)
Mean age ± SD (range)	41± 15 (20–66)
Disease duration median years (range)	12 (1–38)
Localization
Pancolitis (E3)	25 (86%)
Left colitis (E2)	4 (15%)
Proctosigmoiditis (E1)	0
Mayo endoscopy score (MES)
Mayo 0	11 (38%)
Mayo 1	8 (27.5%)
Mayo 2	8 (27.5%)
Mayo 3	2 (7%)
Clinical Mayo
Remission < 2 remission	15 (52%)
Mild 2–4 mild activity	7 (24%)
Moderate 5–7 moderate activity	3 (10%)
Severe > 7 severe activity	4 (14%)
Biological therapy
Adalimumab	3 (10.3%)
Infliximab	1 (3.5%)
Vedolizumab	3 (10.3%)
Ustekinumab	1 (3.5%)
No biological therapy	21 (72.4%)
Medication
Mesalazine	24 (83%)
Steroids	7 (24%)
Immunosuppressants	6 (20%)
CRP mean (range) mg/dL	9 (1–33)
FC mean (range) mcg/gram	656 (30–2363)